Literature DB >> 16989374

Bronchoscopic study on aetiology of chronic cough in HIV-infected adults with negative sputum smears for Mycobacterium tuberculosis at Kenyatta National Hospital, Nairobi.

A M Siika1, J M Chakaya, G Revathi, S S Mohamed, K M Bhatt.   

Abstract

OBJECTIVE: To establish the aetiology of chronic cough in HIV-infected patients with negative sputum smears for Acid Fast Bacilli (AFB).
DESIGN: A cross-sectional descriptive study.
SETTING: Kenyatta National Hospital, a tertiary referral centre in Kenya
SUBJECTS: Sixty five HIV-infected adults presenting with chronic cough and negative sputum smears for AFBs.
RESULTS: Sixty-two patients were included in the final analysis. Aetiology of chronic cough was established in 42 (68%) patients. Pneumocystis jiroveci, bacterial pneumonia and Mycobacterium tuberculosis were diagnosed in 22 (35.5%), 17 (27.4%) and 14 (22.5%) patients respectively. Majority (98%) of patients with a diagnosis had multiple causes established in them. Ciprofloxacin had activity against 91% of the isolated organisms while Penicillin was active against 35% only.
CONCLUSION: This study documents Pneumocystis jiroveci pneumonia as a common cause of morbidity in a subset of HIV infected patients with chronic cough and negative sputum smears for AFB in Kenya.

Entities:  

Mesh:

Year:  2006        PMID: 16989374     DOI: 10.4314/eamj.v83i6.9436

Source DB:  PubMed          Journal:  East Afr Med J        ISSN: 0012-835X


  2 in total

1.  What causes symptoms suggestive of tuberculosis in HIV-positive people with negative initial investigations?

Authors:  Y Hanifa; S Toro Silva; A Karstaedt; F Sahid; S Charalambous; V N Chihota; G J Churchyard; A von Gottberg; K McCarthy; M P Nicol; N T Ndlovu; W Stevens; K L Fielding; A D Grant
Journal:  Int J Tuberc Lung Dis       Date:  2019-01-24       Impact factor: 2.373

Review 2.  Pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression.

Authors:  David M Lowe; Molebogeng X Rangaka; Fabiana Gordon; Chris D James; Robert F Miller
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.